|
PFSCF
|
They are a little Under the estimate of $ 11M for H1, probably caused by...
|
|
PFSCF
|
I like the strategy with the orphan drug from plasma. This could hit the...
|
|
PFSCF
|
Still strong on the $ 1.00 target. Still on $ 1.00 target. Beacon...
|
|
PFSCF
|
I would say that for now, there's only attempts to deal this molecule so...
|
|
PFSCF
|
Over all, PLI have a $ 1.00 target with coverage that give no value for the...
|
|
PFSCF
|
The cost of the phase I trial should be around $ 1.5M to $ 2M.
For the plant...
|
|
PFSCF
|
The client don't want to disclose his name because he simply don't...
|
|
PFSCF
|
ProMetic Receives $4.8 Million Order from Octapharma
ProMetic announced...
|
|
PFSCF
|
Looks like a tons of shares at 32 cents.
Meanwhile, Beacon issued an update...
|
|
PFSCF
|
Le board privé existe toujours. Va voir dans ton profil il devrait...
|
|
PFSCF
|
Catnip,
You are already a member of the private group. Go in your profile...
|
|
PFSCF
|
Paway, One other precision. The $ 4.8M won't probably be...
|
|
PFSCF
|
Octapharma is part of the recurring revenues, so it's already included in...
|
|
PFSCF
|
Paway, It's not because there's no news release that nothing...
|
|
PFSCF
|
No dammage on this, as PLI wasn't involved in this product. ...
|
|
PFSCF
|
Because, this the game PLI is playing. Putting slowly the pieces at the right...
|
|
PFSCF
|
The NR don't mentionned numbers, but could worth $ 5M, as it was the...
|
|
PFSCF
|
The NR don't mentionned numbers, but could worth $ 5M, as it was the...
|
|
PFSCF
|
Just notice that Frédéric Dumais bought yesterday 15K shares at 30...
|
|
PFSCF
|
Just notice that Frédéric Dumais bought yesterday 15K shares at 30...
|